A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in Microsatellite Instability-High )MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (KEYNOTE-177)

  • Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/15/HAWKE/427
SSA Reference Number: SSA/16/MonH/110.
Monash Health HREC Ref: 16162X
StatusFinished
Effective start/end date30/09/19 → 29/09/24

Keywords

  • clinical trial
  • phase 3 study
  • colorectal cancer
  • treatment efficacy

Clinical Trial Phase

  • Phase III (a & b)